PD-RX Pharmaceuticals
PDRX · OTC
About PDRX
- Employees
- 0
- Headquarters
- Oklahoma City, Oklahoma
- Listed
- Dec 17, 2001
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Website
- pdrx.com
PDRX key statistics
- Market cap
- 4.79M
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 870
- Volume
- 500
- Open price
- $3.10
- High today
- $3.10
- Low today
- $3.10
- 52 Week high
- $3.35
- 52 Week low
- $2.75
PD-RX Pharmaceuticals (PDRX) at a glance
As of Sep 16, 2026, PD-RX Pharmaceuticals (PDRX) shares are priced at $3.10, giving the company a market cap of 4.79M.
Volume so far is 500 shares, below the average of 870 shares a day.
Over the past year PD-RX Pharmaceuticals has ranged from $2.75 to $3.35, and now sits 58% of the way up that range.
Similar companies
Companies in the same industry as PD-RX Pharmaceuticals
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
- MDEXMadison Technologies$0.0005−37.50%
- SDSTStardust Power$0.02−23.66%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.